Validation of a Regional Citrate Anticoagulation Protocol in Critically Ill Patients on Continuous Renal Replacement Therapy
Recruiting
N/A
Interventional Study
Acute Kidney Injury
ICU Patients
Continuous Renal Replacement Therapy (CRRT)
Electrolytes
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 43 (estimated)
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this study is to evaluate the effectiveness of a modified continuous renal replacement therapy (CRRT) protocol in maintaining electrolyte balance in adult patients with acute kidney injury (AKI) admitted to the intensive care unit (ICU).
The study assesses whether the use of continuous venovenous hemodiafiltration (CVVHDF) with post-filter replacement under citrate anticoagulatio…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
* Age ≥18 years
* Admission to the intensive care unit (ICU)
* Diagnosis of acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT)
* Use of regional citrate anticoagulation during CRRT Exclusion Criteria
* Known allergy or intolerance to citrate
* Contrai…
Contacts